Notably, given that the frequency of genetic alterations in EP300 is less than 2% in treatment-naive pancreatic tumors, there are likely to be additional mechanisms regulating GATA6 expression in basal-like tumors that may be dependent or independent of p300. The gene discussed is EP300; the disease is pancreatic neoplasm.